There are approximately 436,000 head and neck cancer survivors in the United States currently [1], with 5-year survival rates reported at 63.2% for oral cavity and pharynx and 60.6% for larynx [2]. Virtually all head and neck cancer (HNC) patients present with one or more oral or dental complications [3], which can be mild and include discomfort and pain, or more serious, with morbidities such as dysphagia, mucositis, xerostomia or osteoradionecrosis [4–6]. Further, these complications impact quality of life (QOL) long after treatment [5].
http://ift.tt/2hBggYh
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου